In this study, we discover a role of the GPS2 subunit in the progression of NAFLD/NASH in both mice and humans by combining the study of liver-specific Gps2 KO (LKO) mice with correlative analysis of human transcriptome datasets15,16. This evidence concerns the gene GPS2 and metabolic dysfunction-associated steatotic liver disease.